Second Sight Medical (EYES) Reports Q2 Loss of $0.11

Second Sight Medical (NASDAQ: EYES) reported Q2 EPS of ($0.11), versus ($0.12) reported last year. Revenue for the quarter came in at $1.9 million, versus $2.2 million reported last year.

For earnings history and earnings-related data on Second Sight Medical (EYES) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
• Prosensa Holding N.V. (RNA) Reports Q2 Loss of $1.18